Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare, PerkinElmer, Molecular Devices, Beckman Coulter

Premium

GE Healthcare Revenue Rises 7 Percent in Q3

GE Healthcare on Oct. 14 reported revenue of $3.6 billion for its third quarter ended Sept. 30, a 7-percent increase over revenue of $3.3 billion in the third quarter last year.

GE said total orders for GE Healthcare's Q3 were up 8 percent year over year. The services part of the unit reported 9-percent growth to $1.4 million, and the equipment part of the unit posted 7-percent growth to roughly $2.3 billion.

The healthcare unit of the conglomerate posted a quarterly profit of $589 million, a 17 percent increase year over year.

Overall, parent company GE posted revenue of $41.9 billion for the quarter, a 9-percent increase over revenue of $38.3 billion in the comparable quarter a year ago. The firm also reported net earnings of $4.7 billion, up 15 percent from $4.1 billion in the third quarter of 2004.

GE pointed out that all six of its business units — Healthcare, Infrastructure, Commercial Finance, Consumer Finance, Industrial, and NBC Universal — delivered double-digit earnings growth.


PerkinElmer, Molecular Devices, Beckman Coulter Schedule Q3 Earnings Release

PerkinElmer will release its third-quarter 2005 results on Tuesday, Oct. 25, following the close of market trading.

The company will hold a conference call and slide presentation via webcast to discuss the results that same evening, at 5:30 PM Eastern time. Gregory Summe, chairman and CEO, and Robert Friel, executive vice president and chief financial officer, will host the call.

Molecular Devices said it will release its third-quarter 2005 results on Thursday, Oct. 27, after the close of market trading.

Senior management will hold a conference call the following day, Friday, Oct. 28, at 11 AM Eastern time to discuss operating results and other business matters.

Beckman Coulter said it will release its third-quarter 2005 results on Wednesday, Nov. 2, 2005, before the start of regular market trading.

Beckman will host a conference call on that same morning, at 8:30 AM Eastern time to discuss the results. The call will be hosted by Scott Garrett, president and CEO, and James Glover, senior vice president and CFO.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.